New Breast Cancer Research Trial at NYOH

Sep 01, 2016

NYOH is currently enrolling eligible breast cancer patients in a new clinical research trial for Embraca. This Phase III research study is for those with advanced of metastatic breast cancer who also have the inherited BRCA 1 or 2 mutation. 

For more information, please call NYOH 518-489-3612 x1045.

Visit www.newyorkoncology.com/clinical-trials-research/ for a full list of open trials, available at NYOH locations.